ATE235911T1 - Opioidpeptide - Google Patents
OpioidpeptideInfo
- Publication number
- ATE235911T1 ATE235911T1 AT94901304T AT94901304T ATE235911T1 AT E235911 T1 ATE235911 T1 AT E235911T1 AT 94901304 T AT94901304 T AT 94901304T AT 94901304 T AT94901304 T AT 94901304T AT E235911 T1 ATE235911 T1 AT E235911T1
- Authority
- AT
- Austria
- Prior art keywords
- amino acid
- acid selected
- image
- identifying group
- dimethoxyphenylalanine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97494392A | 1992-11-12 | 1992-11-12 | |
| PCT/US1993/010711 WO1994011018A1 (en) | 1992-11-12 | 1993-11-04 | Opioid peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE235911T1 true ATE235911T1 (de) | 2003-04-15 |
Family
ID=25522535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94901304T ATE235911T1 (de) | 1992-11-12 | 1993-11-04 | Opioidpeptide |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5663295A (de) |
| EP (1) | EP0644772B1 (de) |
| JP (1) | JPH07503485A (de) |
| AT (1) | ATE235911T1 (de) |
| AU (1) | AU672077B2 (de) |
| CA (1) | CA2126697A1 (de) |
| CZ (1) | CZ168194A3 (de) |
| DE (1) | DE69332826T2 (de) |
| DK (1) | DK0644772T3 (de) |
| ES (1) | ES2194861T3 (de) |
| NZ (1) | NZ258345A (de) |
| PL (1) | PL304662A1 (de) |
| PT (1) | PT644772E (de) |
| RU (1) | RU94035760A (de) |
| WO (1) | WO1994011018A1 (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IS4261A (is) * | 1994-02-21 | 1995-08-22 | Astra Aktiebolag | Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra |
| EP1164141A3 (de) * | 1994-02-21 | 2002-01-02 | AstraZeneca AB | Opioid-Peptide und ihre Verwendung zur Behandlung von Schmerz |
| AU3673495A (en) | 1995-04-12 | 1996-10-30 | Kyowa Hakko Kogyo Co. Ltd. | Plant cell growth factor |
| CN1202174A (zh) * | 1995-09-11 | 1998-12-16 | 第一制药株式会社 | 肽衍生物 |
| JP3746847B2 (ja) * | 1996-08-02 | 2006-02-15 | 協和醗酵工業株式会社 | 植物細胞増殖因子 |
| US6703381B1 (en) | 1998-08-14 | 2004-03-09 | Nobex Corporation | Methods for delivery therapeutic compounds across the blood-brain barrier |
| TW509699B (en) | 1998-09-24 | 2002-11-11 | Chugau Pharmaceutical Co Ltd | Ethylamine derivatives |
| WO2001036006A1 (en) * | 1999-11-19 | 2001-05-25 | Palatin Technologies, Inc. | Opioid metallopeptide compositions and methods |
| US7163921B1 (en) | 2000-04-14 | 2007-01-16 | Nippon Shinyaku Co., Ltd. | Peptide derivatives and medicinal compositions |
| US20070142287A1 (en) * | 2005-12-20 | 2007-06-21 | Biomed Solutions, Llc | Compositions And Methods For Treatment Of Cancer |
| SG190670A1 (en) * | 2008-02-01 | 2013-06-28 | Gen Hospital Corp | Use of microvesicles in diagnosis, prognosis and treatment of medical diseases and conditions |
| EP3461912B1 (de) | 2009-09-09 | 2022-07-13 | The General Hospital Corporation | Verwendung von mikrovesikeln bei der analyse von nukleinsäureprofilen |
| EP2539358A1 (de) | 2010-02-25 | 2013-01-02 | Pfizer Limited | Peptidanaloga |
| US20140045915A1 (en) | 2010-08-31 | 2014-02-13 | The General Hospital Corporation | Cancer-related biological materials in microvesicles |
| WO2012064993A1 (en) | 2010-11-10 | 2012-05-18 | Exosome Diagnosties, Inc. | Method for isolation of nucleic acid containing particles and extraction of nucleic acids therefrom |
| RU2517628C1 (ru) * | 2012-12-24 | 2014-05-27 | Государственное научное учреждение Всероссийский научно-исследовательский институт мясной промышленности им. В.М. Горбатова Российской академии сельскохозяйственных наук | Способ определения природных аминокислот в составе белков пищевых продуктов |
| JP6525471B2 (ja) | 2013-03-15 | 2019-06-05 | プロタゴニスト セラピューティクス， インコーポレイテッド | ヘプシジン類似体及びその使用 |
| KR20230036156A (ko) | 2014-05-16 | 2023-03-14 | 프로타고니스트 테라퓨틱스, 인코포레이티드 | α4β7 인테그린 티오에테르 펩티드 길항제 |
| CN113563423A (zh) | 2014-07-17 | 2021-10-29 | 领导医疗有限公司 | 白细胞介素-23受体的口服肽抑制剂以及其治疗炎症性肠病的用途 |
| US20190002503A1 (en) | 2015-12-30 | 2019-01-03 | Protagonist Therapeutics, Inc. | Analogues of hepcidin mimetics with improved in vivo half lives |
| CA3073806A1 (en) | 2017-09-11 | 2019-03-14 | Protagonist Therapeutics, Inc. | Opioid agonist peptides and uses thereof |
| JP2021503481A (ja) * | 2017-11-17 | 2021-02-12 | サイトジェル ファーマ リミテッド ライアビリティ カンパニー | μオピオイド受容体のポリマーアゴニスト |
| WO2019157268A1 (en) | 2018-02-08 | 2019-08-15 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| CN115298196A (zh) | 2020-01-15 | 2022-11-04 | 詹森生物科技公司 | 介白素-23受体的肽抑制剂及其治疗炎性疾病的用途 |
| US12018057B2 (en) | 2020-01-15 | 2024-06-25 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| CN111635335B (zh) * | 2020-06-24 | 2021-07-13 | 上海交通大学 | 一种手性γ-氨基酸的合成方法及采用该方法合成的手性γ-氨基酸 |
| IL302996A (en) | 2020-11-20 | 2023-07-01 | Janssen Pharmaceutica Nv | Compositions of peptide inhibitors of the interleukin-23 receptor |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH644352A5 (en) * | 1976-01-26 | 1984-07-31 | Wellcome Found | Process for the preparation of peptides |
| US4216128A (en) * | 1979-07-05 | 1980-08-05 | American Home Products Corporation | Enkephalin analogues |
| US4599325A (en) * | 1984-02-16 | 1986-07-08 | G. D. Searle & Co. | Substituted tyrosyl alanine dipeptide amides |
| US4880778A (en) * | 1986-05-12 | 1989-11-14 | Eastman Kodak Company | Combinations having synergistic growth hormone releasing activity and methods for use thereof |
-
1993
- 1993-11-04 AT AT94901304T patent/ATE235911T1/de not_active IP Right Cessation
- 1993-11-04 DE DE69332826T patent/DE69332826T2/de not_active Expired - Fee Related
- 1993-11-04 EP EP94901304A patent/EP0644772B1/de not_active Expired - Lifetime
- 1993-11-04 NZ NZ258345A patent/NZ258345A/en unknown
- 1993-11-04 RU RU94035760/04A patent/RU94035760A/ru unknown
- 1993-11-04 ES ES94901304T patent/ES2194861T3/es not_active Expired - Lifetime
- 1993-11-04 WO PCT/US1993/010711 patent/WO1994011018A1/en active IP Right Grant
- 1993-11-04 CZ CZ941681A patent/CZ168194A3/cs unknown
- 1993-11-04 PT PT94901304T patent/PT644772E/pt unknown
- 1993-11-04 CA CA002126697A patent/CA2126697A1/en not_active Abandoned
- 1993-11-04 PL PL93304662A patent/PL304662A1/xx unknown
- 1993-11-04 JP JP6512244A patent/JPH07503485A/ja active Pending
- 1993-11-04 AU AU55943/94A patent/AU672077B2/en not_active Ceased
- 1993-11-04 DK DK94901304T patent/DK0644772T3/da active
-
1994
- 1994-12-08 US US08/352,391 patent/US5663295A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69332826T2 (de) | 2004-01-29 |
| AU672077B2 (en) | 1996-09-19 |
| EP0644772B1 (de) | 2003-04-02 |
| PT644772E (pt) | 2003-08-29 |
| CA2126697A1 (en) | 1994-05-26 |
| DE69332826D1 (de) | 2003-05-08 |
| ES2194861T3 (es) | 2003-12-01 |
| PL304662A1 (en) | 1995-01-09 |
| AU5594394A (en) | 1994-06-08 |
| WO1994011018A1 (en) | 1994-05-26 |
| RU94035760A (ru) | 1996-08-10 |
| US5663295A (en) | 1997-09-02 |
| JPH07503485A (ja) | 1995-04-13 |
| NZ258345A (en) | 1996-03-26 |
| DK0644772T3 (da) | 2003-06-30 |
| EP0644772A1 (de) | 1995-03-29 |
| CZ168194A3 (en) | 1994-12-15 |
| EP0644772A4 (de) | 1997-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE235911T1 (de) | Opioidpeptide | |
| MX9304970A (es) | ACIDOS ß-AMINOALQUIL- Y ß-N-PEPTIDILAMINOALQUIL-BORONICOS. | |
| CY1111740T1 (el) | Συζευγματα πεπτιδιων ν- και/ή c-τελικως τροποποιημενα μεσω βραχεων αλυσων φορτισμενων πεπτιδιων | |
| CA2060034A1 (en) | Tumour growth-inhibiting somatostatin analogues, pharmaceutical compositions containing them and process for preparing same | |
| ATE167874T1 (de) | Polypeptid bombesin antagonisten | |
| KR900009692A (ko) | 레트로바이러스 프로테아제 억제제 | |
| KR880012640A (ko) | 포스포리파제 a₂- 억제 작용을 갖는 펩티드 | |
| ES2012720A6 (es) | Procedimiento para la obtencion de sales de adicion de acido de taurina o glicina amidada. | |
| PT1226160E (pt) | Novos peptidos antiarritmicos | |
| KR890701571A (ko) | 4h-3, 1-벤즈옥사진-4-온 화합물 및 세린 프로테아제 억제를 위한 그의 약학 조성물 | |
| KR950005320A (ko) | 위장 운동 자극 활성을 가지는 폴리펩티드 | |
| NZ335879A (en) | Somatostatin antagonist peptides having a D-amino acid at the second residue | |
| DE3751398D1 (de) | Substrat-Peptide. | |
| DE68923572D1 (de) | Peptide. | |
| GB992957A (en) | New decapeptides and their manufacture | |
| FI952455A0 (fi) | Uusia oligopeptidejä, joilla on affiniteetti opioidireseptoreihin | |
| DK0737691T3 (da) | Bombesinanaloger | |
| EP0220923A3 (en) | Dipeptides and process | |
| JPS5225768A (en) | Preparation of novel pentapeptides | |
| EP0311517A3 (de) | Amid-Verbindung mit Glutamatrezeptor inhibierender Wirkung | |
| ES416516A1 (es) | Un procedimiento para la preparacion de nonapeptidos. | |
| KR870007206A (ko) | 폴리펩타이드 화합물 | |
| GB1331714A (en) | Preparation of peptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0644772 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |